Recently, the news has been awash with claims that we’ve discovered the cause of Alzheimer’s disease, and that it’s preventable. These claims are caused by a new study that links the degenerative brain condition to damaging proteins produced by oral bacteria, proteins that can be neutralized by a new drug being developed by a pharmaceutical company that played a part in the research.
While there is some value to the current work, which extends our understanding of the link between gum disease and this form of dementia, we have to understand that the connections are likely very complicated, and the solution is probably more involved than just a single drug.
What Is Gum Disease?
Gum disease is a chronic infection of the mouth. Many different species of oral bacteria colonize the area between the teeth and gums.
Like bacteria that cling to the teeth, these bacteria can release acid and other damaging chemicals to destroy the teeth, gums, and bone. This creates additional living spaces for the bacteria, first periodontal pockets, and later large areas of detached gums. Detached gums can begin to recede from the teeth.
As the number of bacteria around the teeth increases, the body responds. But the body’s response can be the worst part about gum disease. The immune system can attack and destroy the bone around your teeth, leading to loose teeth and even tooth loss. We’re not sure how much of this damage is due to the body exercising a kind of “nuclear option” trying to destroy bacteria along with gums and how much is due to oral bacterial corrupting the immune system.
The bacteria that cause gum disease can travel through the body via your blood vessels, potentially triggering similarly destructive immune responses elsewhere in the body.
The symptoms of Alzheimer’s disease can be mild at first. People have more difficulty remembering recent events than they do remembering details from their childhood. Eventually, people’s memory becomes so badly damaged that they can’t carry on conversations or perform normal everyday tasks.
Physical changes in the brain that correspond to the memory symptoms include the development of plaques and tangles in the brain. Plaques are buildups of a protein called beta-amyloid, Tangles are buildups of the protein tau. These buildups occur in the brain as part of normal aging, but for people with Alzheimer’s disease, the buildup happens more quickly, and follows a predictable sequence, starting with certain memory regions, then expanding out to more of the brain. Protein buildup in the brain has been linked to many potential causes, including sleep apnea, a sleep disorder in which a person wakes up many times a night. There is currently no cure for Alzheimer’s disease. However, treatment may slow the progression of the disease.
Alzheimer’s disease is the sixth leading cause of death in the US.
What Previous Work Has Shown about the Disease Links
The current research is not the first time we’ve seen hints that gum disease and Alzheimer’s disease are linked. Investigation of the link began around 2000, when people started to suspect that systemic inflammation might play a role in Alzheimer’s development.
Systemic inflammation occurs when the body is plagued by chronic infection or other factors that trigger an ongoing immune response. The immune response transitions from a local counter to infection into a system-wide response, with potentially negative effects throughout the body. This research highlighted the role of many potential bacteria.
One common chronic infection is gum disease, which affects about half of all US adults, and two-thirds of adults over 65. As people began to look at the links between gum disease and Alzheimer’s, they found a surprisingly powerful connection.
Many studies started looking at the potential role of gum disease in triggering Alzheimer’s finding biochemical links between inflammatory markers and the brain damage leading to progressing dementia.
The current study looks at the role of one particular oral bacterium in the development of Alzheimer’s disease. Prophyroma gingivalis is a common bacterium in gum disease. Interest zeroed in on P. gingivalisafter a 2013 study showed that it was present in 40% of brains from a sample of Alzheimer’s disease victims, and in no brains of people without Alzheimer’s.
Then in October 2018, researchers published the results of a study showing that if healthy mice were exposed to P. gingivalis and its toxic byproduct, called gingipain, in the mouth for 22 weeks, they began developing brain damage effects that were similar to Alzheimer’s disease. This included damage to the hippocampus, a key memory structure, and buildup of amyloid beta, which likely has an antibacterial role.
The new study expands on this finding, although it is an unconnected study performed by a different research team. This team took brain core samples from postmortem brain samples of people with Alzheimer’s disease and those without. They found that Alzheimer’s disease diagnosis and symptoms correlated with the level of toxic byproducts from oral bacteria found in the brain.
Researchers then performed a similar infection study with mice. They gave mice P. gingivalis orally, and were able to show that the bacteria moved to the brain, leading to the buildup of amyloid beta. Then researchers tried the infection step again, only this time they applied an inhibitor that targeted key gingipains P. gingivalis relies on to spread through the body. This prevented the spread of the bacteria to the brain, and, therefore, stopped the buildup of amyloid beta.
A Promising Start
This research definitely shows a promising start for a potential preventive treatment for Alzheimer’s disease, but it’s far from the breakthrough it is sometimes made out to be. First of all, the evidence establishing the link between P. gingivalis and Alzheimer’s disease is getting stronger, but we don’t yet know if this is the only oral bacterium that can lead to Alzheimer’s development. We also don’t know about the potential role of tooth infection in Alzheimer’s development.
In the current study, we can’t neglect the role of researchers from Cortexyme, which hopes to market its gingipain blockers. We also have to keep in mind that any preventive like this would likely have to be taken for years, even decades to prevent the spread of a common oral bacterium to the brain. Even assuming it’s effective, clinical trials are very bad at detecting long-term harms from drugs that need to be taken on this time frame.
Preserving Your Oral and Overall Health
It’s likely that a better solution to help protect yourself from Alzheimer’s disease is taking good care of your oral health. You can reduce your risk of developing gum disease with thorough oral hygiene supplemented by regular dental checkups and professional cleanings.
And if you do develop gum disease, treatment can take care of the infection, stopping the impact of chronic systemic infection on your body, including possibly Alzheimer’s disease.
If you are looking for a dentist in Tulsa, OK, please call (918) 528-3330 today for an appointment at élan by Meghan Hodges.